Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Teva Partners with Schreiner MediPharm for Novel Adrenaline Injector Label | Contract Pharma
Breaking News

Teva Partners with Schreiner MediPharm for Novel Adrenaline Injector Label

Multi-functional specialty label keeps product and user information visible.

Schreiner MediPharm, a Germany-based global provider of functional label solutions for the pharmaceutical industry, has developed an Autoinjector-Label with special protection against abrasion for the allergy emergency drug epinephrine from Teva. Allowing vital user and product information to remain legible over an extended period of time, the label won an award in the 2019 TLMI Competition. 
 
The label developed by Schreiner MediPharm for Teva’s adrenaline injector is provided with abrasion- and scratch-resistant reverse printing. As a result, it is particularly resistant against chemical and mechanical impacts it may encounter while being carried, for example, in a purse or backpack. 
 
Due to its special material construction and design adapted to the autoinjector’s shape, the marking label securely adheres to the device. Thus, the vital product and user information is reliably legible and readily available at all times. An additional cover protecting the label against abrasion or separation is not necessary, which reduces waste and environmental footprint. For product and patient safety, the label features a perforation that clearly and irreversibly indicates any first opening of the cap and thus any potential tampering attempt.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters